Mount Sinai receives $500K to enhance pancreatic cancer care

Edna Cukierman awarded ACS Wilmott Family Professorship in Pancreatic Cancer

Edna “Eti” Cukierman, co-director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute and co-leader of the Cancer Signaling and Microenvironment Research Program at Fox Chase Cancer Center, was recently awarded the American Cancer Society’s Wilmott Family Professorship in Pancreatic Cancer.

November 17, 2023

Vol.49 No.43

In Brief

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

The Department of Immunology and Immunotherapy and the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai has received a $5 million grant from NCI to establish a center dedicated to the discovery and development of cutting-edge targets for cancer therapy.

November 17, 2023

Vol.49 No.43

Clinical Roundup

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

Researchers at the Mount Sinai Center for Transformative Disease Modeling have released a groundbreaking study identifying 4,749 key gene clusters, termed “prognostic modules,” that significantly influence the progression of 32 different types of cancer.

November 17, 2023

Vol.49 No.43

In Brief

Mark Kelley, Melissa Fishel receive $2.4M NCI grant to develop pancreatic cancer treatments

Mark KelleyMelissa FishelMark Kelley and Melissa Fishel, two researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, received a five-year, $2.4 million grant from NCI to explore therapies that target the critical pathways pancreatic tumors use to survive.

November 10, 2023

Vol.49 No.42

Clinical Roundup

NCI-designated subspecialist reviews improve 94% of pancreatic cancer treatment paths

A study published in Journal of Personalized Medicine explores how oncology subspecialist reviews of pancreatic adenocarcinoma cases can identify care gaps and provide recommendations intended to improve treatment outcomes.

October 27, 2023

Vol.49 No.40

Clinical Roundup

PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find

Mount Sinai researchers have discovered a link between certain per- and polyfluoroalkyl substances and an increased risk for thyroid cancer, according to a study published in eBioMedicine.

October 27, 2023

Vol.49 No.40

Mount Sinai receives $500K to enhance pancreatic cancer care

YOU MAY BE INTERESTED IN

Edna Cukierman awarded ACS Wilmott Family Professorship in Pancreatic Cancer

Icahn School of Medicine at Mount Sinai receives $5M NCI grant for NIH Cancer Target Discovery and Development Center

Mount Sinai researchers find more than 4,700 gene clusters crucial for prognosis in 32 cancer types

Mark Kelley, Melissa Fishel receive $2.4M NCI grant to develop pancreatic cancer treatments

NCI-designated subspecialist reviews improve 94% of pancreatic cancer treatment paths

PFAS forever chemicals could be a risk factor in thyroid cancer, Mount Sinai researchers find

Renew today!

Subscriber content

Login